Faulk Pharmaceuticals Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Faulk Pharmaceuticals General Information

Description

Technology assets used in the production of cancer-fighting drugs. The technology assets include a patent protected, ligand-drug conjugate technology platform, as well as a pipeline of drug product candidates.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Raleigh, NC 27615
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Faulk Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Faulk Pharmaceuticals‘s full profile, request access.

Request a free trial

Faulk Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Page Faulke Chief Executive Officer
To view Faulk Pharmaceuticals’s complete executive team members history, request access »